Tuesday, April 24, 2018 12:11:16 AM
Malaria: GeoVax has demonstrated in both animal models and humans that its MVA-VLP vaccines induce a
Th1-biased response with both durable functional antibodies (IgG1 and IgG3) and CD4+ and CD8+ T cell
responses—both marks of an ideal malaria vaccine.
Cancer: GeoVax has a research
collaboration with a leading expert in cancer immunotherapy at the University of Pittsburgh to help select vaccine
candidates. The Company is further collaborating with ViaMune, Inc. of Athens, Georgia, with preliminary testing
demonstrating that the MVA-VLP-MUC1 vaccine, in combination with ViaMune’s synthetic MUC1 vaccine, may
meaningfully reduce tumor burden in a transgenic (Tg) human MUC1 therapeutic mouse model. GeoVax believes
that this program has the potential to generate several vaccines against different types of cancers.
Zika: To date, GeoVax has demonstrated 100%
protection of mice vaccinated with a single-dose of the Zika vaccine and exposed to a lethal dose of ZIKV.
Background: All of GeoVax’s preventative vaccine trials
have been sponsored by the NIH, with the NIH (through the HIV Vaccine Trials Network [HVTN]), in fact, running
the Company’s trials—something that is unusual within the biotechnology space.
Each of GeoVax’s preventative
vaccine trials have been sponsored by the NIH, garnering GeoVax roughly $50 million in either research support or
in-kinds funds—presenting a very unique circumstance for GeoVax.
WE deserve 100*300M mc easy...
Recent GOVX News
- GeoVax to Participate in Upcoming Investor Conferences in September • GlobeNewswire Inc. • 09/03/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:15:02 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/30/2024 01:38:39 PM
- GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market • GlobeNewswire Inc. • 08/29/2024 12:59:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:19:01 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/21/2024 01:22:03 PM
- Registration is Now Open for Tribe Public’s Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO • GlobeNewswire Inc. • 08/21/2024 01:00:00 PM
- GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market • GlobeNewswire Inc. • 08/20/2024 11:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:12:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:11:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:10:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:10:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:09:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:09:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:08:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:07:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:07:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:06:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:06:04 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/13/2024 04:15:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 12:47:49 PM
- GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board • GlobeNewswire Inc. • 08/08/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:05:39 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/06/2024 09:17:09 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/06/2024 09:16:20 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM